COVID-19 Outbreak-Global NSCLS Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
COVID-19 Outbreak-Global NSCLS Drugs Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
Insights into the NSCLS Drugs Market include supply chain optimization, NSCLS Drugs challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
The NSCLS Drugs market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the NSCLS Drugs industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The NSCLS Drugs market can be split based on product types, major applications, and important countries as follows:
Key players in the global NSCLS Drugs market covered in Chapter 12:
AstraZeneca
Celgene
Pfizer
QIAGEN NV
Novartis
OSI Pharmaceuticals
Roche
Boehringer Ingelheim
Eli Lilly and Company
Genentech
In Chapter 4 and 14.1, on the basis of types, the NSCLS Drugs market from 2015 to 2025 is primarily split into:
Erlotinib (Tarceva and others)
Afatinib (Gilotrif)
Gefitinib (Iressa)
Bevacizumab (Avastin)
Crizotinib (Xalkori)
Ceritinib (Zykadia)
Others
In Chapter 5 and 14.2, on the basis of applications, the NSCLS Drugs market from 2015 to 2025 covers:
Squamous Cell Carcinoma
Large Cell Carcinoma
Adenocarcinoma
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Table of Content
1 NSCLS Drugs Introduction and Market Overview
1.1 Objectives of the Study
1.2 Overview of NSCLS Drugs
1.3 Scope of The Study
1.3.1 Key Market Segments
1.3.2 Players Covered
1.3.3 COVID-19's impact on the NSCLS Drugs industry
1.4 Methodology of The Study
1.5 Research Data Source
2 Executive Summary
2.1 Market Overview
2.1.1 Global NSCLS Drugs Market Size, 2015 – 2020
2.1.2 Global NSCLS Drugs Market Size by Type, 2015 – 2020
2.1.3 Global NSCLS Drugs Market Size by Application, 2015 – 2020
2.1.4 Global NSCLS Drugs Market Size by Region, 2015 - 2025
2.2 Business Environment Analysis
2.2.1 Global COVID-19 Status and Economic Overview
2.2.2 Influence of COVID-19 Outbreak on NSCLS Drugs Industry Development
3 Industry Chain Analysis
3.1 Upstream Raw Material Suppliers of NSCLS Drugs Analysis
3.2 Major Players of NSCLS Drugs
3.3 NSCLS Drugs Manufacturing Cost Structure Analysis
3.3.1 Production Process Analysis
3.3.2 Manufacturing Cost Structure of NSCLS Drugs
3.3.3 Labor Cost of NSCLS Drugs
3.4 Market Distributors of NSCLS Drugs
3.5 Major Downstream Buyers of NSCLS Drugs Analysis
3.6 The Impact of Covid-19 From the Perspective of Industry Chain
3.7 Regional Import and Export Controls Will Exist for a Long Time
3.8 Continued downward PMI Spreads Globally
4 Global NSCLS Drugs Market, by Type
4.1 Global NSCLS Drugs Value and Market Share by Type (2015-2020)
4.2 Global NSCLS Drugs Production and Market Share by Type (2015-2020)
4.3 Global NSCLS Drugs Value and Growth Rate by Type (2015-2020)
4.3.1 Global NSCLS Drugs Value and Growth Rate of Erlotinib (Tarceva and others)
4.3.2 Global NSCLS Drugs Value and Growth Rate of Afatinib (Gilotrif)
4.3.3 Global NSCLS Drugs Value and Growth Rate of Gefitinib (Iressa)
4.3.4 Global NSCLS Drugs Value and Growth Rate of Bevacizumab (Avastin)
4.3.5 Global NSCLS Drugs Value and Growth Rate of Crizotinib (Xalkori)
4.3.6 Global NSCLS Drugs Value and Growth Rate of Ceritinib (Zykadia)
4.3.7 Global NSCLS Drugs Value and Growth Rate of Others
4.4 Global NSCLS Drugs Price Analysis by Type (2015-2020)
5 NSCLS Drugs Market, by Application
5.1 Downstream Market Overview
5.2 Global NSCLS Drugs Consumption and Market Share by Application (2015-2020)
5.3 Global NSCLS Drugs Consumption and Growth Rate by Application (2015-2020)
5.3.1 Global NSCLS Drugs Consumption and Growth Rate of Squamous Cell Carcinoma (2015-2020)
5.3.2 Global NSCLS Drugs Consumption and Growth Rate of Large Cell Carcinoma (2015-2020)
5.3.3 Global NSCLS Drugs Consumption and Growth Rate of Adenocarcinoma (2015-2020)
6 Global NSCLS Drugs Market Analysis by Regions
6.1 Global NSCLS Drugs Sales, Revenue and Market Share by Regions
6.1.1 Global NSCLS Drugs Sales by Regions (2015-2020)
6.1.2 Global NSCLS Drugs Revenue by Regions (2015-2020)
6.2 North America NSCLS Drugs Sales and Growth Rate (2015-2020)
6.3 Europe NSCLS Drugs Sales and Growth Rate (2015-2020)
6.4 Asia-Pacific NSCLS Drugs Sales and Growth Rate (2015-2020)
6.5 Middle East and Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
6.6 South America NSCLS Drugs Sales and Growth Rate (2015-2020)
7 North America NSCLS Drugs Market Analysis by Countries
7.1 The Influence of COVID-19 on North America Market
7.2 North America NSCLS Drugs Sales, Revenue and Market Share by Countries
7.2.1 North America NSCLS Drugs Sales by Countries (2015-2020)
7.2.2 North America NSCLS Drugs Revenue by Countries (2015-2020)
7.3 United States NSCLS Drugs Sales and Growth Rate (2015-2020)
7.4 Canada NSCLS Drugs Sales and Growth Rate (2015-2020)
7.5 Mexico NSCLS Drugs Sales and Growth Rate (2015-2020)
8 Europe NSCLS Drugs Market Analysis by Countries
8.1 The Influence of COVID-19 on Europe Market
8.2 Europe NSCLS Drugs Sales, Revenue and Market Share by Countries
8.2.1 Europe NSCLS Drugs Sales by Countries (2015-2020)
8.2.2 Europe NSCLS Drugs Revenue by Countries (2015-2020)
8.3 Germany NSCLS Drugs Sales and Growth Rate (2015-2020)
8.4 UK NSCLS Drugs Sales and Growth Rate (2015-2020)
8.5 France NSCLS Drugs Sales and Growth Rate (2015-2020)
8.6 Italy NSCLS Drugs Sales and Growth Rate (2015-2020)
8.7 Spain NSCLS Drugs Sales and Growth Rate (2015-2020)
8.8 Russia NSCLS Drugs Sales and Growth Rate (2015-2020)
9 Asia Pacific NSCLS Drugs Market Analysis by Countries
9.1 The Influence of COVID-19 on Asia Pacific Market
9.2 Asia Pacific NSCLS Drugs Sales, Revenue and Market Share by Countries
9.2.1 Asia Pacific NSCLS Drugs Sales by Countries (2015-2020)
9.2.2 Asia Pacific NSCLS Drugs Revenue by Countries (2015-2020)
9.3 China NSCLS Drugs Sales and Growth Rate (2015-2020)
9.4 Japan NSCLS Drugs Sales and Growth Rate (2015-2020)
9.5 South Korea NSCLS Drugs Sales and Growth Rate (2015-2020)
9.6 India NSCLS Drugs Sales and Growth Rate (2015-2020)
9.7 Southeast Asia NSCLS Drugs Sales and Growth Rate (2015-2020)
9.8 Australia NSCLS Drugs Sales and Growth Rate (2015-2020)
10 Middle East and Africa NSCLS Drugs Market Analysis by Countries
10.1 The Influence of COVID-19 on Middle East and Africa Market
10.2 Middle East and Africa NSCLS Drugs Sales, Revenue and Market Share by Countries
10.2.1 Middle East and Africa NSCLS Drugs Sales by Countries (2015-2020)
10.2.2 Middle East and Africa NSCLS Drugs Revenue by Countries (2015-2020)
10.3 Saudi Arabia NSCLS Drugs Sales and Growth Rate (2015-2020)
10.4 UAE NSCLS Drugs Sales and Growth Rate (2015-2020)
10.5 Egypt NSCLS Drugs Sales and Growth Rate (2015-2020)
10.6 Nigeria NSCLS Drugs Sales and Growth Rate (2015-2020)
10.7 South Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
11 South America NSCLS Drugs Market Analysis by Countries
11.1 The Influence of COVID-19 on Middle East and Africa Market
11.2 South America NSCLS Drugs Sales, Revenue and Market Share by Countries
11.2.1 South America NSCLS Drugs Sales by Countries (2015-2020)
11.2.2 South America NSCLS Drugs Revenue by Countries (2015-2020)
11.3 Brazil NSCLS Drugs Sales and Growth Rate (2015-2020)
11.4 Argentina NSCLS Drugs Sales and Growth Rate (2015-2020)
11.5 Columbia NSCLS Drugs Sales and Growth Rate (2015-2020)
11.6 Chile NSCLS Drugs Sales and Growth Rate (2015-2020)
12 Competitive Landscape
12.1 AstraZeneca
12.1.1 AstraZeneca Basic Information
12.1.2 NSCLS Drugs Product Introduction
12.1.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.2 Celgene
12.2.1 Celgene Basic Information
12.2.2 NSCLS Drugs Product Introduction
12.2.3 Celgene Production, Value, Price, Gross Margin 2015-2020
12.3 Pfizer
12.3.1 Pfizer Basic Information
12.3.2 NSCLS Drugs Product Introduction
12.3.3 Pfizer Production, Value, Price, Gross Margin 2015-2020
12.4 QIAGEN NV
12.4.1 QIAGEN NV Basic Information
12.4.2 NSCLS Drugs Product Introduction
12.4.3 QIAGEN NV Production, Value, Price, Gross Margin 2015-2020
12.5 Novartis
12.5.1 Novartis Basic Information
12.5.2 NSCLS Drugs Product Introduction
12.5.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.6 OSI Pharmaceuticals
12.6.1 OSI Pharmaceuticals Basic Information
12.6.2 NSCLS Drugs Product Introduction
12.6.3 OSI Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
12.7 Roche
12.7.1 Roche Basic Information
12.7.2 NSCLS Drugs Product Introduction
12.7.3 Roche Production, Value, Price, Gross Margin 2015-2020
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Basic Information
12.8.2 NSCLS Drugs Product Introduction
12.8.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.9 Eli Lilly and Company
12.9.1 Eli Lilly and Company Basic Information
12.9.2 NSCLS Drugs Product Introduction
12.9.3 Eli Lilly and Company Production, Value, Price, Gross Margin 2015-2020
12.10 Genentech
12.10.1 Genentech Basic Information
12.10.2 NSCLS Drugs Product Introduction
12.10.3 Genentech Production, Value, Price, Gross Margin 2015-2020
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global NSCLS Drugs Market Forecast
14.1 Global NSCLS Drugs Market Value & Volume Forecast, by Type (2020-2025)
14.1.1 Erlotinib (Tarceva and others) Market Value and Volume Forecast (2020-2025)
14.1.2 Afatinib (Gilotrif) Market Value and Volume Forecast (2020-2025)
14.1.3 Gefitinib (Iressa) Market Value and Volume Forecast (2020-2025)
14.1.4 Bevacizumab (Avastin) Market Value and Volume Forecast (2020-2025)
14.1.5 Crizotinib (Xalkori) Market Value and Volume Forecast (2020-2025)
14.1.6 Ceritinib (Zykadia) Market Value and Volume Forecast (2020-2025)
14.1.7 Others Market Value and Volume Forecast (2020-2025)
14.2 Global NSCLS Drugs Market Value & Volume Forecast, by Application (2020-2025)
14.2.1 Squamous Cell Carcinoma Market Value and Volume Forecast (2020-2025)
14.2.2 Large Cell Carcinoma Market Value and Volume Forecast (2020-2025)
14.2.3 Adenocarcinoma Market Value and Volume Forecast (2020-2025)
14.3 NSCLS Drugs Market Analysis and Forecast by Region
14.3.1 North America Market Value and Consumption Forecast (2020-2025)
14.3.2 Europe Market Value and Consumption Forecast (2020-2025)
14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)
14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)
14.3.5 South America Market Value and Consumption Forecast (2020-2025)
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
List of Tables and Figures
Figure Product Picture of NSCLS Drugs
Table Product Specification of NSCLS Drugs
Table NSCLS Drugs Key Market Segments
Table Key Players NSCLS Drugs Covered
Figure Global NSCLS Drugs Market Size, 2015 – 2025
Table Different Types of NSCLS Drugs
Figure Global NSCLS Drugs Value ($) Segment by Type from 2015-2020
Figure Global NSCLS Drugs Market Share by Types in 2019
Table Different Applications of NSCLS Drugs
Figure Global NSCLS Drugs Value ($) Segment by Applications from 2015-2020
Figure Global NSCLS Drugs Market Share by Applications in 2019
Figure Global NSCLS Drugs Market Share by Regions in 2019
Figure North America NSCLS Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Europe NSCLS Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Asia Pacific NSCLS Drugs Production Value ($) and Growth Rate (2015-2020)
Figure Middle East and Africa NSCLS Drugs Production Value ($) and Growth Rate (2015-2020)
Figure South America NSCLS Drugs Production Value ($) and Growth Rate (2015-2020)
Table Global COVID-19 Status and Economic Overview
Figure Global COVID-19 Status
Figure COVID-19 Comparison of Major Countries
Figure Industry Chain Analysis of NSCLS Drugs
Table Upstream Raw Material Suppliers of NSCLS Drugs with Contact Information
Table Major Players Headquarters, and Service Area of NSCLS Drugs
Figure Major Players Production Value Market Share of NSCLS Drugs in 2019
Table Major Players NSCLS Drugs Product Types in 2019
Figure Production Process of NSCLS Drugs
Figure Manufacturing Cost Structure of NSCLS Drugs
Figure Channel Status of NSCLS Drugs
Table Major Distributors of NSCLS Drugs with Contact Information
Table Major Downstream Buyers of NSCLS Drugs with Contact Information
Table Global NSCLS Drugs Value ($) by Type (2015-2020)
Table Global NSCLS Drugs Value Share by Type (2015-2020)
Figure Global NSCLS Drugs Value Share by Type (2015-2020)
Table Global NSCLS Drugs Production by Type (2015-2020)
Table Global NSCLS Drugs Production Share by Type (2015-2020)
Figure Global NSCLS Drugs Production Share by Type (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Erlotinib (Tarceva and others) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Afatinib (Gilotrif) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Gefitinib (Iressa) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Bevacizumab (Avastin) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Crizotinib (Xalkori) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Ceritinib (Zykadia) (2015-2020)
Figure Global NSCLS Drugs Value ($) and Growth Rate of Others (2015-2020)
Figure Global NSCLS Drugs Price by Type (2015-2020)
Figure Downstream Market Overview
Table Global NSCLS Drugs Consumption by Application (2015-2020)
Table Global NSCLS Drugs Consumption Market Share by Application (2015-2020)
Figure Global NSCLS Drugs Consumption Market Share by Application (2015-2020)
Figure Global NSCLS Drugs Consumption and Growth Rate of Squamous Cell Carcinoma (2015-2020)
Figure Global NSCLS Drugs Consumption and Growth Rate of Large Cell Carcinoma (2015-2020)
Figure Global NSCLS Drugs Consumption and Growth Rate of Adenocarcinoma (2015-2020)
Figure Global NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Global NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table Global NSCLS Drugs Sales by Regions (2015-2020)
Table Global NSCLS Drugs Sales Market Share by Regions (2015-2020)
Table Global NSCLS Drugs Revenue (M USD) by Regions (2015-2020)
Table Global NSCLS Drugs Revenue Market Share by Regions (2015-2020)
Table Global NSCLS Drugs Revenue Market Share by Regions in 2015
Table Global NSCLS Drugs Revenue Market Share by Regions in 2019
Figure North America NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Europe NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Asia-Pacific NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Middle East and Africa NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South America NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure North America COVID-19 Confirmed Cases Major Distribution
Figure North America NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table North America NSCLS Drugs Sales by Countries (2015-2020)
Table North America NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table North America NSCLS Drugs Revenue (M USD) by Countries (2015-2020)
Table North America NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure United States NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Canada NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Mexico NSCLS Drugs Sales and Growth (2015-2020)
Figure Europe COVID-19 Status
Figure Europe COVID-19 Confirmed Cases Major Distribution
Figure Europe NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table Europe NSCLS Drugs Sales by Countries (2015-2020)
Table Europe NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table Europe NSCLS Drugs Revenue (M USD) by Countries (2015-2020)
Table Europe NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Germany NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure UK NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure France NSCLS Drugs Sales and Growth (2015-2020)
Figure Italy NSCLS Drugs Sales and Growth (2015-2020)
Figure Spain NSCLS Drugs Sales and Growth (2015-2020)
Figure Russia NSCLS Drugs Sales and Growth (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Asia Pacific NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table Asia Pacific NSCLS Drugs Sales by Countries (2015-2020)
Table Asia Pacific NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table Asia Pacific NSCLS Drugs Revenue (M USD) by Countries (2015-2020)
Table Asia Pacific NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure China NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Japan NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure South Korea NSCLS Drugs Sales and Growth (2015-2020)
Figure India NSCLS Drugs Sales and Growth (2015-2020)
Figure Southeast Asia NSCLS Drugs Sales and Growth (2015-2020)
Figure Australia NSCLS Drugs Sales and Growth (2015-2020)
Figure Middle East NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table Middle East NSCLS Drugs Sales by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Revenue (M USD) by Countries (2015-2020)
Table Middle East and Africa NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Saudi Arabia NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure UAE NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Egypt NSCLS Drugs Sales and Growth (2015-2020)
Figure Nigeria NSCLS Drugs Sales and Growth (2015-2020)
Figure South Africa NSCLS Drugs Sales and Growth (2015-2020)
Figure South America NSCLS Drugs Revenue (M USD) and Growth (2015-2020)
Table South America NSCLS Drugs Sales by Countries (2015-2020)
Table South America NSCLS Drugs Sales Market Share by Countries (2015-2020)
Table South America NSCLS Drugs Revenue (M USD) by Countries (2015-2020)
Table South America NSCLS Drugs Revenue Market Share by Countries (2015-2020)
Figure Brazil NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Argentina NSCLS Drugs Sales and Growth Rate (2015-2020)
Figure Columbia NSCLS Drugs Sales and Growth (2015-2020)
Figure Chile NSCLS Drugs Sales and Growth (2015-2020)
Figure Top 3 Market Share of NSCLS Drugs Companies in 2019
Figure Top 6 Market Share of NSCLS Drugs Companies in 2019
Table Major Players Production Value ($) Share (2015-2020)
Table AstraZeneca Profile
Table AstraZeneca Product Introduction
Figure AstraZeneca Production and Growth Rate
Figure AstraZeneca Value ($) Market Share 2015-2020
Table Celgene Profile
Table Celgene Product Introduction
Figure Celgene Production and Growth Rate
Figure Celgene Value ($) Market Share 2015-2020
Table Pfizer Profile
Table Pfizer Product Introduction
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table QIAGEN NV Profile
Table QIAGEN NV Product Introduction
Figure QIAGEN NV Production and Growth Rate
Figure QIAGEN NV Value ($) Market Share 2015-2020
Table Novartis Profile
Table Novartis Product Introduction
Figure Novartis Production and Growth Rate
Figure Novartis Value ($) Market Share 2015-2020
Table OSI Pharmaceuticals Profile
Table OSI Pharmaceuticals Product Introduction
Figure OSI Pharmaceuticals Production and Growth Rate
Figure OSI Pharmaceuticals Value ($) Market Share 2015-2020
Table Roche Profile
Table Roche Product Introduction
Figure Roche Production and Growth Rate
Figure Roche Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Profile
Table Boehringer Ingelheim Product Introduction
Figure Boehringer Ingelheim Production and Growth Rate
Figure Boehringer Ingelheim Value ($) Market Share 2015-2020
Table Eli Lilly and Company Profile
Table Eli Lilly and Company Product Introduction
Figure Eli Lilly and Company Production and Growth Rate
Figure Eli Lilly and Company Value ($) Market Share 2015-2020
Table Genentech Profile
Table Genentech Product Introduction
Figure Genentech Production and Growth Rate
Figure Genentech Value ($) Market Share 2015-2020
Table Market Driving Factors of NSCLS Drugs
Table Merger, Acquisition and New Investment
Table Global NSCLS Drugs Market Value ($) Forecast, by Type
Table Global NSCLS Drugs Market Volume Forecast, by Type
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Erlotinib (Tarceva and others) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Erlotinib (Tarceva and others) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Afatinib (Gilotrif) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Afatinib (Gilotrif) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Gefitinib (Iressa) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Gefitinib (Iressa) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Bevacizumab (Avastin) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Bevacizumab (Avastin) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Crizotinib (Xalkori) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Crizotinib (Xalkori) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Ceritinib (Zykadia) (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Ceritinib (Zykadia) (2020-2025)
Figure Global NSCLS Drugs Market Value ($) and Growth Rate Forecast of Others (2020-2025)
Figure Global NSCLS Drugs Market Volume ($) and Growth Rate Forecast of Others (2020-2025)
Table Global Market Value ($) Forecast by Application (2020-2025)
Table Global Market Volume Forecast by Application (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Squamous Cell Carcinoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Squamous Cell Carcinoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Large Cell Carcinoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Large Cell Carcinoma (2020-2025)
Figure Market Value ($) and Growth Rate Forecast of Adenocarcinoma (2020-2025)
Figure Market Volume and Growth Rate Forecast of Adenocarcinoma (2020-2025)
Figure North America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure North America Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Europe Consumption and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Value ($) and Growth Rate Forecast (2020-2025)
Figure South America Consumption and Growth Rate Forecast (2020-2025)
Figure Porter’s Five Forces Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Research Methodology:
NSCLS Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|